Erratum: Opportunities for therapeutic antibodies directed at G-protein-coupled receptors

Nature Reviews Drug Discovery 16 (2017) In the article, the clinical trial for the biparatopic CXCR2 nanobody was described as being for cancer instead of inflammation. This error has been corrected in the online version.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Drug discovery 2017-09, Vol.16 (9), p.661-661
Hauptverfasser:	Hutchings, Catherine J., Koglin, Markus, Olson, William C., Marshall, Fiona H.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154/51/1568 631/45/612/194 692/699/249/2510 692/699/317 Biomedical and Life Sciences Biomedicine Biotechnology Cancer Research corrigendum Erratum Medicinal Chemistry Molecular Medicine Pharmacology/Toxicology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Nature Reviews Drug Discovery 16 (2017) In the article, the clinical trial for the biparatopic CXCR2 nanobody was described as being for cancer instead of inflammation. This error has been corrected in the online version.
ISSN:	1474-1776 1474-1784
DOI:	10.1038/nrd.2017.173